New scan could help doctors plan better liver cancer treatment
NCT ID NCT02881554
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 28 times
Summary
This study tested a special type of scan (SPECT/CT) that uses a safe radioactive tracer to measure how well the liver is working in people with liver cancer. The goal was to see if the scan could track changes in liver function before, during, and after radiation or surgery. About 41 adults with liver cancer took part. The study was stopped early, but the information gathered may help doctors plan more personalized treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
ProCure Proton Therapy Center-Seattle
Seattle, Washington, 98133, United States
Conditions
Explore the condition pages connected to this study.